Presence and progression of white matter hyperintensities and cognition: A meta-analysis

Neurology

Volumn 82, Issue 23, 2014, Pages 2127-2138

  Kloppenborg, Raoul P ^a,b,c   Nederkoorn, Paul J ^a   Geerlings, Mirjam I ^b   Van Den Berg, Esther ^d,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Julius Center for Health Sciences and Primary Care   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; EFFECT SIZE; EXECUTIVE FUNCTION; HUMAN; INTELLIGENCE; LONGITUDINAL STUDY; MEMORY; META ANALYSIS; PERCEPTION; PRIORITY JOURNAL; VELOCITY; WHITE MATTER;

COGNITION DISORDERS; DISEASE PROGRESSION; HUMANS; LEUKOENCEPHALOPATHIES;

EID: 84903954145     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000505     Document Type: Article

References (60)

1. Wardlaw JM, Smith EE, Biessels GJ, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12: 822-838.
2. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70: 9-14.
3. Conijn MM, Kloppenborg RP, Algra A, et al SMART Study Group. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the second manifestations of ARTerial disease-magnetic resonance (SMARTMR) study. Stroke 2011;42: 3105-3109.
4. Silbert LC, Nelson C, Howieson DB, et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008;71: 108-113.
5. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-Analysis. BMJ 2010;341: c3666.
6. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14: 224-232.
7. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005;36: 56-61.
8. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005; 58: 610-616.
9. de Leeuw FE, Korf E, Barkhof F, Scheltens P. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease. Stroke 2006;37: 2248-2252.
10. Kloppenborg RP, Nederkoorn PJ, Grool AM, et al. Cerebral small vessel disease and progression of brain atrophy: the SMART-MR study. Neurology 2012;79: 2029-2036.
11. Henskens LH, Kroon AA, van Oostenbrugge RJ, et al. Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients. J Hypertens 2009;27: 1446-1452.
12. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47: 145-151.
13. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62: e1-34.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 2009;339: b2535.
15. Akisaki T, Sakurai T, Takata T, et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006;22: 376-384.
16. Geerlings MI, Appelman AP, Vincken KL, et al SMART Study Group. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study. Am J Epidemiol 2009;170: 1147-1155.
17. Imamine R, Kawamura T, Umemura T, et al. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract 2011;94: 91-99.
18. Manschot SM, Brands AM, van der Grond J, et al Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55: 1106-1113.
19. Schmidt R, Fazekas F, Koch M, et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects: a casecontrol study. Arch Neurol 1995;52: 905-910.
20. van den Heuvel DMJ, ten Dam VH, de Craen AJM, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a nondemented elderly population. J Neurol Neurosurg Psychiatry 2006;77: 149-153.
21. Benisty S, Gouw AA, Porcher R, et al; LADIS Study group. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009;80: 478-483.
22. Jokinen H, Gouw AA, Madureira S, et al LADIS Study Group. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011;76: 1872-1878.
23. Lipsey MW, Wilson DB. Practical Meta-Analysis. Thousand Oaks, CA: Sage Publications; 2001.
24. Rosenthal R. Meta-Analytic Procedures for Social Research. Newbury Park, CA: Sage; 1991.
25. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
26. Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological Assessment, 5th ed. Oxford: Oxford University Press; 2012.
27. Hedges L, Olkin I. Statistical Methods for Meta-Analysis. Orlando: Academic Press; 1985.
28. Hedges LV. Distribution theory for Glass's estimator of effect sizes and related estimates. J Educ Stat 1981;6: 107-128.
29. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-Analysis. Stat Med 2002;21: 1539-1558.
30. Rosenberg MS, Adams DC, Gurevitch J. MetaWin. Statistical Software for Meta-Analysis, version 2.0. Sunderland, MA: Sinauer Associates; 2000.
31. Salarirad S, Staff RT, Fox HC, Deary IJ, Whalley L, Murray AD. Childhood intelligence and brain white matter hyperintensities predict fluid intelligence age 78-81 years: a 1921 Aberdeen birth cohort study. Age Ageing 2011;40: 562-567.
32. Mayda AB, Westphal A, Carter CS, DeCarli C. Late life cognitive control deficits are accentuated by white matter disease burden. Brain 2011;134: 1673-1683.
33. Marquine MJ, Attix DK, Goldstein LB, et al. Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. Stroke 2010;41: 1946-1950.
34. Aggarwal NT, Wilson RS, Bienias JL, et al. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol 2010;67: 475-482.
35. Wakefield DB, Moscufo N, Guttmann CR, et al. White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults. J Am Geriatr Soc 2010;58: 275-281.
36. Vannorsdall TD, Waldstein SR, Kraut M, et al. White matter abnormalities and cognition in a community sample. Arch Clin Neuropsychol 2009;24: 209-217.
37. Vernooij MW, Ikram MA, Vrooman HA, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009; 66: 545-553.
38. Baune BT, Roesler A, Knecht S, Berger K. Single and combined effects of cerebral white matter lesions and lacunar infarctions on cognitive function in an elderly population. J Gerontol A Biol Sci Med Sci 2009;64: 118-124.
39. Koga H, Takashima Y, Murakawa R, et al. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals. J Stroke Cerebrovasc Dis 2009;18: 32-37.
40. Dalaker TO, Larsen JP, Dwyer MG, et al. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. Neuroimage 2009;47: 2083-2089.
41. Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008;39: 397-402.
42. Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006;63: 246-250.
43. Söderlund H, Nilsson LG, Berger K, et al. Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiol Aging 2006;27: 16-23.
44. Shenkin SD, Bastin ME, Macgillivray TJ, et al. Cognitive correlates of cerebral white matter lesions and water diffusion tensor parameters in community-dwelling older people. Cerebrovasc Dis 2005;20: 310-318.
45. Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005;64: 2056-2062.
46. Van Petten C, Plante E, Davidson PS, et al. Memory and executive function in older adults: relationships with temporal and prefrontal gray matter volumes and white matter hyperintensities. Neuropsychologia 2004;42: 1313-1335.
47. Söderlund H, Nyberg L, Adolfsson R, et al. High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition. Cortex 2003;39: 1093-1105.
48. Leaper SA, Murray AD, Lemmon HA, et al. Neuropsychologic correlates of brain white matter lesions depicted on MR images: 1921 Aberdeen Birth Cohort. Radiology 2001;221: 51-55.
49. Garde E, Mortensen EL, Krabbe K, et al. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000;356: 628-634.
50. DeCarli C, Murphy DG, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45: 2077-2084.
51. Schmidt R, Fazekas F, Koch M, et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects. Arch Neurol 1995;52: 905-910.
52. Breteler MMB, van Amerongen N, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: the Rotterdam Study. Stroke 1994;25: 1109-1115.
53. Godin O, Tzourio C, Rouaud O, et al. Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI study. J Alzheimers Dis 2010;20: 453-463.
54. Christensen H, Batterham PJ, Mackinnon AJ, et al. Education, atrophy, and cognitive change in an epidemiological sample in early old age. Am J Geriatr Psychiatry 2009; 17: 218-226.
55. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128: 2034-2041.
56. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998;51: 986-993.
57. Wolfson L, Wakefield DB, Moscufo N, et al. Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons. J Gerontol A Biol Sci Med Sci 2013;68: 1387-1394.
58. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77: 461-468.
59. Kramer JH, Mungas D, Reed BR, et al. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007;21: 412-418.
60. Garde E, Lykke Mortensen E, Rostrup E, Paulson OB. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 2005;76: 1289-1291.